Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is a...
Q2 2026
Aug 6, 2026
Q1 2026
May 13, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q3 2025
Nov 13, 2025